• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Anticancer activity of natural and semi-synthetic drimane and coloratane sesquiterpenoids
 
  • Details
  • Full
Options
2022
Review
Title

Anticancer activity of natural and semi-synthetic drimane and coloratane sesquiterpenoids

Abstract
Drimane and coloratane sesquiterpenoids are present in several plants, microorganisms, and marine life. Because of their cytotoxic activity, these sesquiterpenoids have received increasing attention as a source for new anticancer drugs and pharmacophores. Natural drimanes and coloratanes, as well as their semi-synthetic derivatives, showed promising results against cancer cell lines with in vitro activities in the low micro- and nanomolar range. Despite their high potential as novel anticancer agents, the mode of action and structure–activity relationships of drimanes and coloratanes have not been completely enlightened nor systematically reviewed. Our review aims to give an overview of known structures and derivatizations of this class of sesquiterpenoids, as well as their activity against cancer cells and potential modes-of-action. The cytotoxic activities of about 40 natural and 25 semi-synthetic drimanes and coloratanes are discussed. In addition to that, we give a summary about the clinical significance of drimane and coloratane sesquiterpenoids.
Author(s)
Beckmann, Lorenz
Universität Leipzig  
Tretbar, Sandy  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Kitte, Reni  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Tretbar, Maik
Universität Leipzig  
Journal
Molecules  
Open Access
DOI
10.3390/molecules27082501
Additional link
Full text
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • Natural products

  • Organic synthesis

  • Anticancer activity

  • Mode-of-action

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024